Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;36(3):307-310.
doi: 10.1097/INF.0000000000001424.

Who Gets Severe Gynecomastia Among HIV-infected Children in the United Kingdom and Ireland?

Julia Kenny  1 , Katja Doerholt, Di M Gibb, Ali Judd; Collaborative HIV Paediatric Study (CHIPS) Steering Committee
Affiliations

Who Gets Severe Gynecomastia Among HIV-infected Children in the United Kingdom and Ireland?

Julia Kenny et al. Pediatr Infect Dis J. 2017 Mar.

Abstract

There are few data on gynecomastia in HIV-infected children. Within the UK/Ireland's national cohort, 56 of 1873 (3%) HIV-infected children had gynecomastia, of which 10 (0.5%) were severe. All 10 had received antiretroviral therapy for a median of 27.5 (21, 42) months; 4 of 10 had received efavirenz, 7 of 10 and 6 of 10 had received stavudine and/or didanosine respectively. Five were nonreversible, despite changing antiretroviral therapy, and required breast reduction surgery.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: No conflicts of interest declared.

References

    1. Caso JA, et al. Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz. Aids. 2001;15(11):1447–8. - PubMed
    1. Jover F, et al. Efavirenz-associated gynecomastia: report of five cases and review of the literature. Breast J. 2004;10(3):244–6. - PubMed
    1. Mira JA, et al. Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment. Antivir Ther. 2004;9(4):511–7. - PubMed
    1. Qazi NA, et al. Gynaecomastia without lipodystrophy in HIV-1-seropositive patients on efavirenz: an alternative hypothesis. Aids. 2002;16(3):506–7. - PubMed
    1. Dzwonek A, et al. Severe gynecomastia in an African boy with perinatally acquired human immunodeficiency virus infection receiving highly active antiretroviral therapy. Pediatr Infect Dis J. 2006;25(2):183–4. - PubMed

Publication types

Substances